EPIREAD
Live / Applied — Statement of use — final refusal mailed (as of 03 Feb 2026)
What this means for you
Not registered yet, but its 02 Feb 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98977343
- Mark type
- Stylized text
- Filed
- 02 Feb 2024
- Published for opposition
- 07 Jan 2025
- Attorney of record
- Michael J. Allan
Goods and services
- Class 042 — Scientific and technological services: Research and development in the field of pharmaceuticals, therapeutics, and biotechnology; Conducting research and clinical trials for others relating to pharmaceuticals in the fields of age-related, autoimmune, cardiometabolic, cardiovascular, dermatological, endocrine, epigenetic, gastrointestinal, genetic, hematological, hemoglobinopathy, immunological, infectious, liver, metabolic, muscular dystrophy, neurodegenerative, neuropsychiatric, oncological, ophthalmological, pediatric, psychiatric, pulmonary, renal, reproductive, respiratory, and skeletal diseases; Conducting research and clinical trials for others relating to veterinary pharmaceuticals in the fields of age-related, autoimmune, cardiometabolic, cardiovascular, dermatological, endocrine, epigenetic, gastrointestinal, genetic, hematological, hemoglobinopathy, immunological, infectious, liver, metabolic, muscular dystrophy, neurodegenerative, neuropsychiatric, oncological, ophthalmological, psychiatric, pulmonary, renal, reproductive, respiratory, and skeletal diseases
Owner
- Moonwalk Biosciences, South San Francisco, CA, US
- Moonwalk Biosciences, South San Francisco, CA, US
Prosecution history
- 03 Feb 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 03 Feb 2026 — FINAL REFUSAL E-MAILED
- 03 Feb 2026 — SU - FINAL REFUSAL - WRITTEN
- 03 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Feb 2026 — ASSIGNED TO LIE
- 27 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 06 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Jan 2026 — NON-FINAL ACTION E-MAILED
- 06 Jan 2026 — SU - NON-FINAL ACTION - WRITTEN
- 05 Jan 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 11 Jul 2026 — USE AMENDMENT FILED
- 05 Jan 2026 — DIVISIONAL PROCESSING COMPLETE
- 11 Jul 2025 — DIVISIONAL REQUEST RECEIVED
- 05 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL